CIDRAP newsletters options
Upwards of 700,000—perhaps as many as 1.6 million—US COVID-19 survivors haven't recovered their sense of smell after more than 6 months, according to a research letter yesterday in JAMA Otolaryngology-Head & Neck Surgery.
Austria, Germany, and the Netherlands all report record high daily cases.
COVID-19 interventions might worsen loneliness, financial stress, and other mental health issues.
Kansas, Louisiana, Maine, and Rhode Island become the latest to expand eligibility for COVID-19 boosters.
Data suggest that interest in antibiotic R&D and in curbing environmental impact is growing.
The US Centers for Disease Control and Prevention (CDC) published a new comprehensive survey of vaccine uptake in healthcare workers (HCWs), showing that after initial enthusiasm, vaccine uptake stalled at 70% by Sep 15, 2021. Results of the survey are published in the American Journal of Infection Control.
By the end of today 2.6 million young American children will have gotten their first shot.
Data show that people taking immunosuppressive drugs, including cancer patients, are not at higher risk.
For the 4th week in a row, the rate of new global COVID-19 cases rose, led by surges in Europe.
A coalition of organizations from academia, healthcare, and the pharmaceutical industry sent a letter today to G7 governments calling for greater engagement in tackling antimicrobial resistance (AMR) and boosting the pipeline for new antibiotics.
New research from the Mayo Clinic shows monoclonal antibodies reduce the risk of hospitalization 77% in 1,395 patients who had breakthrough COVID-19 infections. The research was published yesterday in the Journal of Infectious Diseases.
More than 95% of the state's available inpatient hospital beds are filled with patients.
Of the patients taking fluoxetine (Prozac), 9.8% died, versus 13.3% of control patients, a 28% reduction.
Pfizer has applied for emergency use authorization from the FDA for Paxlovid, its COVID-19 drug.
An automated text messaging system for adult COVID-19 outpatients developed at Penn Medicine saved two lives a week during the first US pandemic surge, and users were 68% less likely than controls to die, finds a study today in the Annals of Internal Medicine.
A report today from Scotland highlights reduced antibiotic use in the country since it adopted a One Health approach to combatting antimicrobial resistance (AMR).
COVID-19, however, has slowed progress and much work remains, a global survey reveals.
Women need resources to navigate this uncertain time, the authors say.
Most Americans will take precautions for Thanksgiving, a new poll shows, as a hold on a federal vaccine mandate is upheld.
About 65% of Austrians are vaccinated, a low level for Western Europe.
